Patents

News

Patent losses hit Novartis hard, but CEO has a plan

Novartis CEO Vas Narasimhan says the company is equipped to ride out "the largest patent expiry" in its history," but 2026 will still be tricky.

Sales & Marketing

Patent spelled out in wooden blocks on top of legal documents

The hidden IP problem holding innovators back

For organisations active in the US market, the impact of patent marking is financial, not administrative.

News

AbbVie lifted by lengthy delay to generics of Rinvoq

Shares in AbbVie were lifted today after the company revealed that it has settled patent litigation with generic drugmakers on blockbuster Rinvoq.

News

Could a Novo error set up early GLP-1 generics in Canada?

Reports say Novo Nordisk may have inadvertently let generics of its GLP-1 drug semaglutide for diabetes and obesity launch in Canada early next year.

Market Access

Therapeutic or cosmetic? Patent strategies for dual-use inno...

In the pharmaceutical and cosmetic sectors, innovation often stems from discovering new applications for known compounds.

Digital

AI as an inventor: Defining ownership in the pharma sector

The global pharmaceutical industry is witnessing a surge in innovation, with the industry experiencing a 5% growth in the number of AI-related patent applications in Q1 2024 and

Patent losses hit Novartis hard, but CEO has a plan

The hidden IP problem holding innovators back

AbbVie lifted by lengthy delay to generics of Rinvoq

Could a Novo error set up early GLP-1 generics in Canada?

Therapeutic or cosmetic? Patent strategies for dual-use inno...

AI as an inventor: Defining ownership in the pharma sector

FDA approves higher Wegovy dose via 4th priority voucher

Using AI-driven synthetic personas to take your insights fur...

Patents

Editor's Picks